This activity is intended for internal CCAD Physicians
Activity Description:
This activity is a multidisciplinary forum dedicated to the standardized management of endocrine tumors. This activity focuses on optimizing the diagnosis and treatment of thyroid, adrenal, and parathyroid disorders through evidence-based discussions. Key topics include standardized approaches to thyroid cancer management, indications for radioactive iodine therapy, and best practices in diagnosing and treating adrenal and parathyroid disorders. By fostering collaboration among endocrinologists, surgeons, radiologists, and other specialists, this tumor board ensures a comprehensive, patient-centered approach to endocrine oncology care.
Target Audience:
Endocrinology, Endocrine Surgery, Neurosurgery, Pathology, Radiology, Oncology, Internal Medicine
Learning Objectives:
Participants will be able to achieve the below:
- Management of thyroid cancer: standardized approach
- Indications for radioactive iodine therapy in thyroid cancer
- Diagnosis and management of adrenal disorders & parathyroid disorders: Standardized approach
Faculty Disclosure:
In accordance with the Standards for Integrity and Independence issued by the Accreditation Council for Continuing Medical Education (ACCME), Cleveland Clinic Abu Dhabi for Continuing Education mitigates all faculty conflicts of interest to ensure CME activities are free of commercial bias.
Activity Director(s): Samer El-Kaissi, MD
The planning committee, faculty, and others in control of content (either individually or as a group) have NO relevant financial relationship(s) to disclose with ineligible companies.*
*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.
Accreditation Statement:
Cleveland Clinic Abu Dhabi is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education.
Credit Designation:
This CME Activity is accredited with 1.00 AMA PRA Category 1 Credits™ Participants should claim only the credit commensurate with the extent of their participation in the activity.